Celltrion
068270.KS
#852
Rank
ยฃ20.43 B
Marketcap
ยฃ93.41
Share price
1.32%
Change (1 day)
-4.04%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): ยฃ1.42

According to Celltrion 's latest financial reports the company's current EPS (TTM) is ยฃ1.42. In 2023 the company made an earnings per share (EPS) of ยฃ2.07 a decrease over its 2022 EPS that were of ยฃ2.11.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)ยฃ1.42
2023ยฃ2.07-2.08%
2022ยฃ2.11-11.72%
2021ยฃ2.392.03%
2020ยฃ2.3482.8%
2019ยฃ1.2818.31%
2018ยฃ1.08-36.33%
2017ยฃ1.70161.25%
2016ยฃ0.652.86%
2015ยฃ0.6317.84%
2014ยฃ0.545.87%
2013ยฃ0.51-70.85%
2012ยฃ1.74134.09%
2011ยฃ0.7443.59%
2010ยฃ0.5274.49%
2009ยฃ0.30317.8%
2008ยฃ0.07111-71.7%
2007ยฃ0.25